01/23/23 8:00 AMNYSE : A, DGX Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy TestAgilent Technologies Inc. today announced an agreement with Quest Diagnostics, the world’ s leading provider of diagnostic information services. “We are looking forward to the Quest Diagnostics alliance facilitating broad access to ctDx FIRST, our liquid biopsy solution,” said Paul Beresford, vice president and general manager of Agilent’ s Companion...RHEA-AIvery positive
01/18/23 1:23 PMNYSE : A Agilent Included in Just Capital’s 2023 List of Most Just CompaniesAgilent Technologies Inc. is ranked 35 among the top 100 Most JUST companies, the fifth year the company has been included in the annual list by Just Capital and CNBC. Just Capital and CNBC based the rankings on a review of the policies and practices of 1,000 of the largest U.S. public companies on issues that matter most to Americans, including wages and benefits,...RHEA-AIvery positive
01/09/23 4:30 PMNYSE : A buybackAgilent Authorizes $2 Billion Share Repurchase ProgramAgilent Technologies Inc. today announced that its board of directors has approved a new share repurchase program. “Agilent is committed to balanced capital deployment that drives growth and helps deliver strong returns for shareholders,” said Bob McMahon, Agilent chief financial officer.“ This share repurchase program is a key element of that strategy.”.RHEA-AIneutral
01/09/23 8:45 AMNYSE : A Agilent Investing $725 Million to Expand State-of-the-Art Manufacturing Capacity for Production of Nucleic Acid-Based TherapeuticsAgilent Technologies Inc. today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’ s high-quality active pharmaceutical ingredients. A rendering of the proposed manufacturing facility in Frederick,...RHEA-AIvery positive
01/06/23 8:00 AMNYSE, Nasdaq : A, AKYA partnershipAgilent and Akoya Biosciences Announce Partnership to Drive Multiplex Tissue Assay Development for Biopharma ApplicationsAgilent Technologies, Inc. today announced a partnership with Akoya Biosciences, Inc., The Spatial Biology Company ®, to develop multiplex-immunohistochemistry diagnostic solutions for tissue...RHEA-AIvery positive
01/04/23 8:45 AMNYSE : A acquisitionAgilent Announces Acquisition of Avida Biomed, Developer of High-Performance NGS Target Enrichment Workflows for Cancer ResearchAgilent Technologies Inc. today announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing approaches to study cancer. “The team of talented scientists and genomics industry...RHEA-AIvery positive
12/16/22 1:30 PMNYSE : A conferencesAgilent to Present at Goldman Sachs and J.P. Morgan Healthcare ConferencesAgilent Technologies Inc. today announced that CEO Mike McMullen and CFO Bob McMahon will present at the Goldman Sachs Healthcare CEOs Unscripted Conference and the J.P. Morgan Healthcare Conference. Goldman Sachs Healthcare CEOs Unscripted Conference Goldman Sachs Conference Center| New York Date: Jan. 5, 2023 Time: 2:05 p.m. ET. J.P. Morgan Healthcare...RHEA-AIneutral
12/12/22 8:50 PMNYSE : A fda approvalAgilent Resolution ctDx FIRST Receives FDA Approval as a Liquid Biopsy Companion Diagnostic Test for Advanced Non-small Cell Lung CancerAgilent Technologies Inc. announced today that the U.S. Food and Drug Administration has approved Agilent Resolution ctDx FIRST as a companion diagnostic to identify advanced non-small cell lung cancer patients with KRAS G12C mutations who may benefit from treatment with KRAZATI TM. “Expanding access to accurate and fast genomic profiling is an...RHEA-AIpositive
12/07/22 1:44 PMNYSE : A Agilent Again Named to Newsweek’s List of America’s Most Responsible CompaniesAgilent Technologies Inc. today announced the company is ranked 101 in Newsweek’ s 2023 list of America’ s Most Responsible Companies, up 28 places from 2022. To formulate the rankings, Newsweek and business intelligence firm Statista, Inc. reviewed corporate social responsibility and financial reports, analyzed quantitative data, and surveyed 13,000 U.S....RHEA-AIpositive
12/05/22 8:00 AMNYSE : A Agilent Opens Customer Experience Center Highlighting Genomics and Diagnostics SolutionsAgilent Technologies Inc. today announced the opening of a new Customer Experience Center in Lexington, MA, focused on solutions from Agilent genomics and diagnostics product portfolios. The facility will serve as a regional hub for Agilent representatives to showcase and demonstrate both product capabilities and complete workflow solutions to...RHEA-AIvery positive